These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8531933)

  • 1. Short therapy for tinea unguium with terbinafine: four different courses of treatment.
    Albanese G; Di Cintio R; Martini C; Nicoletti A
    Mycoses; 1995; 38(5-6):211-4. PubMed ID: 8531933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short term treatment of dermatophyte onychomycosis with terbinafine.
    Goodfield MJ; Andrew L; Evans EG
    BMJ; 1992 May; 304(6835):1151-4. PubMed ID: 1392793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
    Gupta AK; Lynch LE; Kogan N; Cooper EA
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic Dermatophytes Survive in Nail Lesions During Oral Terbinafine Treatment for Tinea Unguium.
    Iwanaga T; Ushigami T; Anzawa K; Mochizuki T
    Mycopathologia; 2017 Aug; 182(7-8):673-679. PubMed ID: 28281037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.
    Baran R; Feuilhade M; Combernale P; Datry A; Goettmann S; Pietrini P; Viguie C; Badillet G; Larnier C; Czernielewski J
    Br J Dermatol; 2000 Jun; 142(6):1177-83. PubMed ID: 10848743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
    Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
    Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
    De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.
    Tausch I; Bräutigam M; Weidinger G; Jones TC
    Br J Dermatol; 1997 May; 136(5):737-42. PubMed ID: 9205509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
    Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
    Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
    Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
    J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of dermatophyte infection of the finger- and toe-nails with terbinafine (SF 86-327, Lamisil), an orally active fungicidal agent.
    Goodfield MJ; Rowell NR; Forster RA; Evans EG; Raven A
    Br J Dermatol; 1989 Dec; 121(6):753-7. PubMed ID: 2532927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.
    Bräutigam M; Nolting S; Schopf RE; Weidinger G
    BMJ; 1995 Oct; 311(7010):919-22. PubMed ID: 7580551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial.
    Goodfield MJ
    Br J Dermatol; 1992 Feb; 126 Suppl 39():33-5. PubMed ID: 1531926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.
    Elewski BE; Ghannoum MA; Mayser P; Gupta AK; Korting HC; Shouey RJ; Baker DR; Rich PA; Ling M; Hugot S; Damaj B; Nyirady J; Thangavelu K; Notter M; Parneix-Spake A; Sigurgeirsson B
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):287-94. PubMed ID: 22181693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.